Study of Ibrutinib and Rituximab in Treatment Naïve Follicular Lymphoma
Pharmacyclics LLC.
Pharmacyclics LLC.
Eli Lilly and Company
AbbVie
Hoffmann-La Roche
Lyell Immunopharma, Inc.
Genmab
Dartmouth-Hitchcock Medical Center
Acerta Pharma BV
Regeneron Pharmaceuticals
Eli Lilly and Company
Eli Lilly and Company
Novartis
Grifols Therapeutics LLC
The Affiliated People's Hospital of Ningbo University
Memorial Sloan Kettering Cancer Center
Bayer
Monash University
BeiGene
Universität des Saarlandes
Celgene
Genmab
Pharmacyclics LLC.
Celgene
Eli Lilly and Company
University of Liverpool
Angiocrine Bioscience
Denovo Biopharma LLC
Genmab
Bayer
Hoffmann-La Roche
MEI Pharma, Inc.
Institut Paoli-Calmettes
University of Giessen
Bnai Zion Medical Center
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
South Tees Hospitals NHS Foundation Trust
Nanjing Yoko Biomedical Co., Ltd.
Bayer
Teva Branded Pharmaceutical Products R&D, Inc.
Universität des Saarlandes
Oncternal Therapeutics, Inc
Goethe University
Celgene
Amgen
Hoffmann-La Roche
Northwell Health
Medical College of Wisconsin
Seagen Inc.
CTI BioPharma
Spectrum Pharmaceuticals, Inc